Strategies to reengage patients lost to follow up in HIV care in high income countries, a scoping review.
Cohort studies
HIV
Linkage
Lost to follow-up
Reengagement
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
28 08 2021
28 08 2021
Historique:
received:
01
02
2021
accepted:
06
08
2021
entrez:
29
8
2021
pubmed:
30
8
2021
medline:
15
9
2021
Statut:
epublish
Résumé
Despite remarkable achievements in antiretroviral therapy (ART), losses to follow-up (LTFU) might prevent the long-term success of HIV treatment and might delay the achievement of the 90-90-90 objectives. This scoping review is aimed at the description and analysis of the strategies used in high-income countries to reengage LTFU in HIV care, their implementation and impact. A scoping review was done following Arksey & O'Malley's methodological framework and recommendations from Joanna Briggs Institute. Peer reviewed articles were searched for in Pubmed, Scopus and Web of Science; and grey literature was searched for in Google and other sources of information. Documents were charted according to the information presented on LTFU, the reengagement procedures used in HIV units in high-income countries, published during the last 15 years. In addition, bibliographies of chosen articles were reviewed for additional articles. Twenty-eight documents were finally included, over 80% of them published in the United States later than 2015. Database searches, phone calls and/or mail contacts were the most common strategies used to locate and track LTFU, while motivational interviews and strengths-based techniques were used most often during reengagement visits. Outcomes like tracing activities efficacy, rates of reengagement and viral load reduction were reported as outcome measures. This review shows a recent and growing trend in developing and implementing patient reengagement strategies in HIV care. However, most of these strategies have been implemented in the United States and little information is available for other high-income countries. The procedures used to trace and contact LTFU are similar across reviewed studies, but their impact and sustainability are widely different depending on the country studied.
Sections du résumé
BACKGROUND
Despite remarkable achievements in antiretroviral therapy (ART), losses to follow-up (LTFU) might prevent the long-term success of HIV treatment and might delay the achievement of the 90-90-90 objectives. This scoping review is aimed at the description and analysis of the strategies used in high-income countries to reengage LTFU in HIV care, their implementation and impact.
METHODS
A scoping review was done following Arksey & O'Malley's methodological framework and recommendations from Joanna Briggs Institute. Peer reviewed articles were searched for in Pubmed, Scopus and Web of Science; and grey literature was searched for in Google and other sources of information. Documents were charted according to the information presented on LTFU, the reengagement procedures used in HIV units in high-income countries, published during the last 15 years. In addition, bibliographies of chosen articles were reviewed for additional articles.
RESULTS
Twenty-eight documents were finally included, over 80% of them published in the United States later than 2015. Database searches, phone calls and/or mail contacts were the most common strategies used to locate and track LTFU, while motivational interviews and strengths-based techniques were used most often during reengagement visits. Outcomes like tracing activities efficacy, rates of reengagement and viral load reduction were reported as outcome measures.
CONCLUSIONS
This review shows a recent and growing trend in developing and implementing patient reengagement strategies in HIV care. However, most of these strategies have been implemented in the United States and little information is available for other high-income countries. The procedures used to trace and contact LTFU are similar across reviewed studies, but their impact and sustainability are widely different depending on the country studied.
Identifiants
pubmed: 34454444
doi: 10.1186/s12889-021-11613-y
pii: 10.1186/s12889-021-11613-y
pmc: PMC8403456
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1596Investigateurs
Jordi Casabona
(J)
Jose M Miró
(JM)
Juliana Reyes
(J)
Andreu Bruguera
(A)
Sergio Moreno
(S)
Yesika Diaz
(Y)
Jordi Aceiton
(J)
Esteve Muntada
(E)
J Casabona
(J)
J M Miró
(JM)
Sergio Moreno
(S)
Yesika Diaz
(Y)
Jordi Aceiton
(J)
J Reyes
(J)
E Muntada
(E)
A Bruguera
(A)
D Podzamczer
(D)
A Imaz
(A)
P Domingo
(P)
J M Llibre
(JM)
G Navarro
(G)
C Cortés
(C)
J Mallolas
(J)
C Manzardo
(C)
J Tiraboschi
(J)
A Curran
(A)
J Burgos
(J)
M Gracia Mateo
(M)
M M Gutierrez
(MM)
J Murillas
(J)
F Segura
(F)
F Homar
(F)
M García-Gasalla
(M)
E Gonzalez
(E)
F Vidal
(F)
J Peraire
(J)
L Force
(L)
E Leon
(E)
A Masabeu
(A)
I Vilaró
(I)
A Orti
(A)
D Dalmau
(D)
A Jaen
(A)
A Almuedo
(A)
E De Lazzari
(E)
D Giralt
(D)
B Raventós
(B)
F Gargoulas
(F)
T Vanrell
(T)
J C Rubia
(JC)
J Vilà
(J)
M Ferrés
(M)
B Morell
(B)
M Tamayo
(M)
J Ambrosioni
(J)
M Laguno
(M)
M Martínez
(M)
J L Blanco
(JL)
F Garcia-Alcaide
(F)
E Martínez
(E)
A Jou
(A)
B Clotet
(B)
M Saumoy
(M)
A Silva
(A)
P Prieto
(P)
J Navarro
(J)
E Ribera
(E)
M Gurgui
(M)
M A Ribas
(MA)
A A Campins
(AA)
F J Fanjul
(FJ)
M Leyes
(M)
M Peñaranda
(M)
L Martin
(L)
H Vilchez
(H)
S Calzado
(S)
M Cervantes
(M)
M J Amengual
(MJ)
M Navarro
(M)
T Payeras
(T)
C Cifuentes
(C)
N Abdulghani
(N)
T Comella
(T)
M Vargas
(M)
C Viladés
(C)
P Barrufet
(P)
Ivan Chivite
(I)
E Chamarro
(E)
C Escrig
(C)
M Cairó
(M)
X Martinez-Lacasa
(X)
R Font
(R)
Sebastián Meyer
(S)
Juanse Hernandez
(J)
Informations de copyright
© 2021. The Author(s).
Références
Health Promot Int. 2018 Apr 1;33(2):325-333
pubmed: 28334739
PLoS One. 2015 Mar 06;10(3):e0118923
pubmed: 25748668
Sex Transm Dis. 2018 Jun;45(6):361-367
pubmed: 29465679
Lancet. 2019 Jun 15;393(10189):2428-2438
pubmed: 31056293
Glob Public Health. 2019 Nov;14(11):1589-1597
pubmed: 31167605
Med Clin (Barc). 2005 Apr 16;124(14):525-31
pubmed: 15847748
J Int Assoc Provid AIDS Care. 2019 Jan-Dec;18:2325958219838858
pubmed: 30950300
AIDS Behav. 2019 Jan;23(Suppl 1):52-60
pubmed: 29637387
PLoS One. 2015 May 26;10(5):e0127726
pubmed: 26011034
Open Forum Infect Dis. 2020 Aug 21;7(9):ofaa369
pubmed: 32995350
JAMA. 2013 Oct 16;310(15):1619-20
pubmed: 24129466
AIDS Behav. 2018 Aug;22(8):2687-2697
pubmed: 29611094
AIDS Care. 2019 Nov;31(11):1420-1426
pubmed: 30821484
N Engl J Med. 2016 Sep 1;375(9):830-9
pubmed: 27424812
J AIDS Clin Res. 2016 Feb;7(2):
pubmed: 27148468
N C Med J. 2018 Jul-Aug;79(4):210-217
pubmed: 29991608
Int J STD AIDS. 2017 Jun;28(7):679-684
pubmed: 27495147
J Acquir Immune Defic Syndr. 2017 Sep 1;76(1):e7-e14
pubmed: 28394820
Drug Alcohol Depend. 2015 Jun 1;151:250-7
pubmed: 25920799
AIDS Behav. 2019 Sep;23(9):2490-2497
pubmed: 30980279
JAMA Intern Med. 2015 Apr;175(4):588-96
pubmed: 25706928
Curr Opin HIV AIDS. 2010 Jul;5(4):298-304
pubmed: 20543604
Enferm Infecc Microbiol Clin (Engl Ed). 2019 Jun - Jul;37(6):361-366
pubmed: 30514587
BMJ Open. 2018 Feb 28;8(2):e018533
pubmed: 29490955
Clin Infect Dis. 2012 Oct;55(8):1124-34
pubmed: 22828593
AIDS Care. 2020 Jan;32(1):76-82
pubmed: 31129991
AIDS Behav. 2018 Jan;22(1):321-324
pubmed: 28451888
J Int Assoc Provid AIDS Care. 2015 Nov-Dec;14 Suppl 1:S3-S34
pubmed: 26527218
AIDS Care. 2017 May;29(5):627-631
pubmed: 27590445
Rev Esp Salud Publica. 2019 Dec 11;93:
pubmed: 31823963
AIDS. 2013 Sep 10;27(14):2271-9
pubmed: 23669157
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
Clin Infect Dis. 2016 Sep 1;63(5):678-686
pubmed: 27217266
AIDS Care. 2015;27(12):1449-54
pubmed: 26605781
AIDS Behav. 2016 May;20(5):951-66
pubmed: 26404014
J Public Health Manag Pract. 2017 May/Jun;23(3):255-263
pubmed: 27902561
J Acquir Immune Defic Syndr. 2019 Sep 1;82 Suppl 1:S33-S41
pubmed: 31425393
AIDS Behav. 2019 Jan;23(Suppl 1):61-69
pubmed: 28975427
Clin Infect Dis. 2013 Oct;57(8):1164-71
pubmed: 23797289
AIDS Patient Care STDS. 2017 May;31(5):222-226
pubmed: 28488904
J Acquir Immune Defic Syndr. 2016 Feb 1;71(2):e44-50
pubmed: 26484741
Open Forum Infect Dis. 2019 Oct 09;6(10):ofz402
pubmed: 31660364
HIV Med. 2008 May;9(5):261-9
pubmed: 18400074
Lancet HIV. 2018 Jun;5(6):e301-e308
pubmed: 29893243
J Acquir Immune Defic Syndr. 2015 Nov 1;70(3):262-8
pubmed: 26068720
J Assoc Nurses AIDS Care. 2020 Sep-Oct;31(5):553-565
pubmed: 31899701